Follow-up of radically treated lung cancer: Review of the literature and recommendations

Imaging Decisions MRI

Volumn 6, Issue 4, 2002, Pages 32-37

  Surmont, Veerle F M ^a   Van Meerbeeck, J P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Lung cancer; Postoperative follow up; Recurrence; Surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; CYTOKERATIN FRAGMENT 19; NEURON SPECIFIC ENOLASE; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

AUTOFLUORESCENCE BRONCHOSCOPY; BRONCHOSCOPY; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DISEASE COURSE; FIBEROPTIC BRONCHOSCOPY; FOLLOW UP; HEALTH CARE COST; HEART DISEASE; HUMAN; LUNG CANCER; LUNG FUNCTION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; METASTASIS; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SPUTUM CYTODIAGNOSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; TUMOR RECURRENCE;

EID: 0036918423     PISSN: 14333317     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1617-0830.2002.60406.x     Document Type: Review

References (22)

1. Ronald F, Rubinstein LV, Weisenberger TH and the Lung Cancer Study Group. Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies. J Clin Oncol 1984; 2: 1352-1358.
2. Perez CA, Pajak TF, Rubin P. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987; 59: 1874-1881.
3. Virgo KS, McKirgan LW, Caputo MC, et al. Post-treatment management options for lung cancer patients. Ann Surg 1995; 222: 770.
4. Walsh GL, O'Connor M, Willis KM, et al. Is follow up of lung cancer patients following resection medically indicated and cost-effective?. Ann Thorac Surg 1995; 60: 1563.
5. Virgo KS, Naunheim KS, McKirgan LW, Kissling ME, Lin JC, Johnson FE. Cost of patient follow-up after potentially curative lung cancer treatment. J Thorac Cardiovasc Surg 1996; 112: 356-363.
6. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer, how often and for what purpose?. Chest 1999; 115: 1494-1499.
7. Virgo KS, Naunheim KS, Coplin MA, Johnson FE. Lung cancer patient follow-up: Motivation of thoracic surgeons. Chest 1998; 114: 1519-1534.
8. Hiebert CA. The 'cured' lung cancer patient: Is follow up by the surgeon worthwhile?. Ann Thorac Surg 1995; 60: 1557.
9. Johnson FE, Naunheim KS, Coplin MA, Virgo KS. How tumor stage affects surgeons' surveillance strategies after lung cancer surgery. Chest 1997; 111: 99-102.
10. Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P, Soler M. Regular follow-up after curative resection on non small cell lung cancer: A real benefit for patients?. Eur Respir J 2002; 19: 464-468.
11. Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A, Depierre A. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000; 70: 1185-1190.
12. Naunheim KS, Virgo KS. Postoperative surveillance following lung cancer resection. Chest Surg Clin North Am 2001; 11: 213-225.
13. Macdonald JS. Carcinoembryonic antigen screening: Pros and cons. Semin Oncol 1999; 26: 556-560.
14. Mitsuyama AK, Tamae K, Suehara N, Nishihara K, Ogawa Y, Iwashita T, Ihara T, Abe Y, Nakahara S, Katsumoto F, Toyoshima S. Postoperative follow-up of patients with early breast cancer: Reappraisal of serum tumor markers. Surg Today 2002; 32: 13-18.
15. Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM. Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002; 69: 25-29.
16. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: The Mayo program. J Occup Environ Med 1986; 28: 746
17. Kaneko M, Eguchi K, Ohmatsu H. Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798.
18. Sone S, Takashima S, Li F. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351: 1242.
19. Henschke CI, McCauley DI, Yankelevits DF, Naidich DP, McGuinnes G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Project: Overall design and from screening. Lancet 1999; 354: 99-105.
20. Frank A, Lefkowitz D, Jaeger S. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995; 32: 1495-1512.
21. Weigel TL, Yousem S, Dacic S, Kosco PJ, Siegfried J, Luketich JD. Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol 2000; 7: 176-180.
22. Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: Results of the initial radiologic and cytologic screening in the John Hopkins Study. Am Rev Respir Dis 1984; 130: 549.